Stevan R. Hubbard

18.5k total citations · 7 hit papers
89 papers, 14.4k citations indexed

About

Stevan R. Hubbard is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Stevan R. Hubbard has authored 89 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 23 papers in Oncology and 14 papers in Cell Biology. Recurrent topics in Stevan R. Hubbard's work include Protein Kinase Regulation and GTPase Signaling (19 papers), Metabolism, Diabetes, and Cancer (17 papers) and Cytokine Signaling Pathways and Interactions (15 papers). Stevan R. Hubbard is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (19 papers), Metabolism, Diabetes, and Cancer (17 papers) and Cytokine Signaling Pathways and Interactions (15 papers). Stevan R. Hubbard collaborates with scholars based in United States, Finland and United Kingdom. Stevan R. Hubbard's co-authors include Moosa Mohammadi, Joseph Schlessinger, Jeffrey H. Till, David Ron, Wayne A. Hendrickson, Lei Wei, Scott G. Clark, Marcella A. Calfon, Heather P. Harding and Huiqing Zeng and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Stevan R. Hubbard

89 papers receiving 14.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA

2002 2.3k citations Stevan R. Hubbard et al. profile →
Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors

1997 960 citations Moosa Mohammadi, Stevan R. Hubbard et al. Science profile →
Protein Tyrosine Kinase Structure and Function

2000 876 citations Stevan R. Hubbard, Jeffrey H. Till profile →
Crystal structure of the tyrosine kinase domain of the human insulin receptor

1994 863 citations Stevan R. Hubbard, Lei Wei et al. profile →
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

1995 805 citations Moosa Mohammadi, Joseph Schlessinger et al. profile →
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

1997 756 citations Stevan R. Hubbard profile →
Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK

2008 512 citations Amy L. Stiegler, Stevan R. Hubbard et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stevan R. Hubbard United States	52	9.6k	3.7k	2.5k	1.4k	1.3k	89	14.4k
Alan L. Schwartz United States	66	9.2k 1.0×	3.5k 0.9×	2.4k 0.9×	1.7k 1.2×	1.3k 1.0×	176	14.3k
Alex Toker United States	73	15.1k 1.6×	3.7k 1.0×	3.1k 1.2×	2.3k 1.7×	943 0.7×	136	20.5k
Dudley K. Strickland United States	75	8.7k 0.9×	3.5k 1.0×	2.4k 1.0×	2.4k 1.8×	1.4k 1.1×	257	21.3k
Andrius Kazlauskas United States	60	9.8k 1.0×	2.2k 0.6×	2.4k 0.9×	2.3k 1.7×	610 0.5×	188	15.1k
Jonathan Backer United States	71	12.6k 1.3×	4.8k 1.3×	1.7k 0.7×	1.7k 1.2×	2.1k 1.6×	147	17.4k
Steven K. Hanks United States	49	13.6k 1.4×	6.3k 1.7×	3.1k 1.2×	1.7k 1.3×	751 0.6×	92	20.8k
Zhou Songyang United States	69	15.1k 1.6×	2.8k 0.8×	2.8k 1.1×	3.1k 2.2×	696 0.5×	193	19.9k
George Panayotou Greece	48	7.9k 0.8×	2.1k 0.6×	1.5k 0.6×	1.6k 1.2×	460 0.4×	155	11.1k
Ivan Gout United Kingdom	52	9.7k 1.0×	2.8k 0.8×	1.7k 0.7×	2.3k 1.7×	378 0.3×	157	12.8k
Tetsu Akiyama Japan	67	13.0k 1.4×	3.0k 0.8×	4.7k 1.8×	1.8k 1.3×	684 0.5×	264	20.0k

Countries citing papers authored by Stevan R. Hubbard

Since Specialization

Citations

This map shows the geographic impact of Stevan R. Hubbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stevan R. Hubbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stevan R. Hubbard more than expected).

Fields of papers citing papers by Stevan R. Hubbard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stevan R. Hubbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stevan R. Hubbard. The network helps show where Stevan R. Hubbard may publish in the future.

Co-authorship network of co-authors of Stevan R. Hubbard

This figure shows the co-authorship network connecting the top 25 collaborators of Stevan R. Hubbard. A scholar is included among the top collaborators of Stevan R. Hubbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stevan R. Hubbard. Stevan R. Hubbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caveney, Nathanael A., Robert A. Saxton, Deepa Waghray, et al.. (2023). Structural basis of Janus kinase trans-activation. Cell Reports. 42(3). 112201–112201. 27 indexed citations

Virtanen, Anniina, T. Haikarainen, Parthasarathy Sampathkumar, et al.. (2023). Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain. Pharmaceuticals. 16(1). 75–75. 15 indexed citations

Wilmes, Stephan, Maximillian Hafer, Julie A. Tucker, et al.. (2020). Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations. Science. 367(6478). 643–652. 115 indexed citations

Li, Shiqing, et al.. (2015). The insulin and IGF1 receptor kinase domains are functional dimers in the activated state. Nature Communications. 6(1). 51 indexed citations

Logue, Eric C., Nicolin Bloch, Ruonan Zhang, et al.. (2014). A DNA Sequence Recognition Loop on APOBEC3A Controls Substrate Specificity. PLoS ONE. 9(5). e97062–e97062. 44 indexed citations

Shan, Yibing, Daniela Ungureanu, Eric T. Kim, et al.. (2014). Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase. Nature Structural & Molecular Biology. 21(7). 579–584. 122 indexed citations

Hubbard, Stevan R.. (2013). The Insulin Receptor: Both a Prototypical and Atypical Receptor Tyrosine Kinase. Cold Spring Harbor Perspectives in Biology. 5(3). a008946–a008946. 110 indexed citations

Qamra, Rohini & Stevan R. Hubbard. (2013). Structural Basis for the Interaction of the Adaptor Protein Grb14 with Activated Ras. PLoS ONE. 8(8). e72473–e72473. 23 indexed citations

Burns, Kristin E., Fiona E. McAllister, Carsten Schwerdtfeger, et al.. (2012). Mycobacterium tuberculosis Prokaryotic Ubiquitin-like Protein-deconjugating Enzyme Is an Unusual Aspartate Amidase. Journal of Biological Chemistry. 287(44). 37522–37529. 18 indexed citations

10.

Stiegler, Amy L., Steven J. Burden, & Stevan R. Hubbard. (2009). Crystal Structure of the Frizzled-Like Cysteine-Rich Domain of the Receptor Tyrosine Kinase MuSK. Journal of Molecular Biology. 393(1). 1–9. 56 indexed citations

11.

Hubbard, Stevan R. & W. Todd Miller. (2007). Receptor tyrosine kinases: mechanisms of activation and signaling. Current Opinion in Cell Biology. 19(2). 117–123. 373 indexed citations

12.

Bergamin, Elisa, Jinhua Wu, & Stevan R. Hubbard. (2006). Structural Basis for Phosphotyrosine Recognition by Suppressor of Cytokine Signaling-3. Structure. 14(8). 1285–1292. 49 indexed citations

13.

Hu, Junjie & Stevan R. Hubbard. (2006). Structural Basis for Phosphotyrosine Recognition by the Src Homology-2 Domains of the Adapter Proteins SH2-B and APS. Journal of Molecular Biology. 361(1). 69–79. 28 indexed citations

14.

Hubbard, Stevan R.. (2005). EGF receptor inhibition: Attacks on multiple fronts. Cancer Cell. 7(4). 287–288. 31 indexed citations

15.

Hubbard, Stevan R.. (2004). Oncogenic Mutations in B-Raf. Cell. 116(6). 764–766. 18 indexed citations

16.

Hubbard, Stevan R.. (2002). Autoinhibitory mechanisms in receptor tyrosine kinases. Frontiers in bioscience. 7(4). d330–340. 41 indexed citations

17.

Ablooglu, Ararat J., Jeffrey H. Till, Kyonghee Kim, et al.. (2000). Probing the Catalytic Mechanism of the Insulin Receptor Kinase with a Tetrafluorotyrosine-containing Peptide Substrate. Journal of Biological Chemistry. 275(39). 30394–30398. 24 indexed citations

18.

Holinski‐Feder, Elke, Michael Weiss, Oliver Brandau, et al.. (1998). Mutation Screening of the BTK Gene in 56 Families With X-Linked Agammaglobulinemia (XLA): 47 Unique Mutations Without Correlation to Clinical Course. PEDIATRICS. 101(2). 276–284. 87 indexed citations

19.

Hubbard, Stevan R., Moosa Mohammadi, & Joseph Schlessinger. (1998). Autoregulatory Mechanisms in Protein-tyrosine Kinases. Journal of Biological Chemistry. 273(20). 11987–11990. 242 indexed citations

20.

Wei, Lei, Stevan R. Hubbard, Wayne A. Hendrickson, & Leland Ellis. (1995). Expression, Characterization, and Crystallization of the Catalytic Core of the Human Insulin Receptor Protein-tyrosine Kinase Domain. Journal of Biological Chemistry. 270(14). 8122–8130. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact